@article{TAU9075,
author = {Anand N. Shridharani and William O. Brant},
title = {The treatment of erectile dysfunction in patients with neurogenic disease},
journal = {Translational Andrology and Urology},
volume = {5},
number = {1},
year = {2016},
keywords = {},
abstract = {Erectile dysfunction (ED) related to compromise of the nervous system is an increasingly common occurrence. This may be due to the multifactorial nature of ED, the myriad of disorders affecting the neurotransmission of erectogenic signals, and improved awareness and diagnosis of ED. Nevertheless, neurogenic ED remains poorly understood and characterized. Disease related factors such as depression, decreased physical and mental function, the burden of chronic illness, and loss of independence may preclude sexual intimacy and lead to ED as well. The amount of data regarding treatment options in subpopulations of differing neurologic disorders remains scarce except for men with spinal cord injury. The treatment options including phosphodiesterase inhibitors, intracavernosal or intraurethral vasoactive agents, vacuum erection devices (VED) and penile prosthetic implantation remain constant. This review discusses the options in specific neurologic conditions, and briefly provides insight into new and future developments that may reshape the management of neurogenic ED.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/9075}
}